RHO6.F 33 (-1.49%)
US7711951043Drug ManufacturersDrug Manufacturers - General

Roche Holding (RHO6.F) Stock Highlights

33 | -1.49%
2024-12-21 00:03:27
Roche is a Swiss biopharmaceutical and diagnostic company. The firms best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Statistics

Range Today
33 33
Volume Today 30
Range 1 Year
27.1 38.5
Volume 1 Year 36.1K
Range 3 Year
27.1 49.48
Volume 3 Year 90.81K
Range 10 Year
22.2 49.48
Volume 10 Year 442.65K

Highlights

Market Capitalization 216.7B (mega)
Floating Shares 727.01M
Current Price 33
Price To Earnings 18.64
Price To Revenue 0.96
Price To Book 0.91
Earnings Per Share 1.77
Dividend Yield 3.87%
Dividend Per Share 1.3
Payout Ratio 75.92%

Performance

Latest -1.49%
1 Month -0.57%
3 Months -5.31%
6 Months +1.85%
1 Year +2.96%
3 Years -28.57%
5 Years -5.36%
10 Years +18.07%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.